NewAmsterdam Pharma
NAMS
Reported
Wednesday, February 26
Q4 expectations are not available for this asset
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | - | -0.51 | - | - |
| Revenue | - | 8.63M | - | - |
WhatIF - Earnings
Expectations are required for WhatIF analysis